Vol 17, No 3 (2021)
Case report
Published online: 2021-05-05

open access

Page views 735
Article views/downloads 453
Get Citation

Connect on Social Media

Connect on Social Media

Pancreatectomy as a form of treatment for leiomyosarcoma metastasis to pancreas — case report and literature review

Martyna Różewicz1, Joanna Pełka1, Jakub Pałucki2, Małgorzata Lenarcik2, Sławomir Falkowski2, Tomasz Olesiński2
Oncol Clin Pract 2021;17(3):128-131.

Abstract

Background: Pancreatic cancers represent about 2% of all malignant tumors. The prognosis for patients is rather poor and the five-year survival is only 9%. Metastases constitute 2–5% of this organ’s tumors, and the management of such cases is determined individually depending on the type of cancer, the patient’s condition and the medical center’s experience. We present a rare case of pancreatic metastasis from a subcutaneous leiomyosarcoma.

Case: A 71-year-old woman with history of leiomyosarcoma — six years ago, two cancer outbreaks, located in the subcutaneous tissue of the thigh and shoulder treated by surgery and adjuvant radiotherapy. After 5 years, a lung metastasis was diagnosed and successfully resected. The following year, CT scan revealed a mass in the pancreas. The patient also complained of epigastric pain and bloating. The biopsy of the lesion confirmed leiomyosarcoma metastasis. The patient underwent 6 cycles of ADIC chemotherapy, after which the tumor size decreased and the laparotomy was performed. The metastasis was well-demarcated and did not infiltrate surrounding tissues, so distal pancreatectomy provided a complete tumor resection There were no complications throughout surgery During 12 months follow up no recurrence was observed.

Conclusions: Due to the relatively rare occurrence, standards for the treatment of pancreatic metastases have not been developed yet. This case shows that treatment by resection of the tumor while maintaining a surgical margin can be considered as a form of treatment in pancreatic secondary cancers.

Article available in PDF format

View PDF Download PDF file

References

  1. Istl AC, Ruck JM, Morris CD, et al. Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS. J Surg Oncol. 2019; 119(7): 824–835.
  2. van Cann T, Cornillie J, Wozniak A, et al. Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center. Oncol Res Treat. 2018; 41(4): 206–213.
  3. Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009; 10(3): 287–293.
  4. Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019; 10(1): 10–27.
  5. Yuasa T, Inoshita N, Saiura A, et al. Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer. 2015; 15: 46.
  6. Serrano C, George S. Leiomyosarcoma. Hematol Oncol Clin North Am. 2013; 27(5): 957–974.
  7. Madkhali AA, Shin SH, Song KiB, et al. Pancreatectomy for a secondary metastasis to the pancreas: A single-institution experience. Medicine (Baltimore). 2018; 97(42): e12653.